Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

This publication has 29 references indexed in Scilit:

• Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified Adenoviruses
  Molecular Therapy, 2002
• 652. Expression and Regulation of the Coxsackie- and Adenovirus Receptor (CAR) in Premalignant Lesions and Advanced Neoplasms
  Molecular Therapy, 2002
• Adenoviral Gene Therapy
  The Oncologist, 2002
• Adenoviruses in Oncology
  BioDrugs, 2002
• Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
  Nature Medicine, 2001
• Thymidine Kinase Gene Therapy for Human Malignant Glioma, Using Replication-Deficient Retroviruses or Adenoviruses
  Human Gene Therapy, 2000
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
  Nature Medicine, 2000
• A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
  Oncogene, 2000
• The Presence of Human Coxsackievirus and Adenovirus Receptor Is Associated with Efficient Adenovirus-Mediated Transgene Expression in Human Melanoma Cell Cultures
  Human Gene Therapy, 1998
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
  Science, 1996